| DRUG WATCH |
|
| Year : 2016 | Volume
: 48
| Issue : 3 | Page : 327-328 |
Severe metabolic changes following oral sodium phosphate in a patient of renal cell carcinoma - On dialysis
Christopher Thiam Seong Lim
Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
Correspondence Address:
Prof. Christopher Thiam Seong Lim
Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor
Malaysia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.182875
Oral sodium phosphate (OSP), an effective bowel purgative, is available over the counter (OTC) and requires a substantially lower volume than polyethylene glycol-based preparative agents. Rarely, OSP consumption has been associated with acute hypocalcemia and hyperphosphatemia. We describe a case of chronic kidney disease patient developing symptomatic hypocalcemia following OTC OSP.
[FULL TEXT] [PDF]*
|
